Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, August 2007, p. 2985-2987, Vol. 51, No. 8
0066-4804/07/$08.00+0 doi:10.1128/AAC.00308-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Department of Pharmaceutics, University of Florida College of Pharmacy,1 Departments of Medicine,2 Molecular Genetics and Microbiology, University of Florida College of Medicine,3 North Florida/South Georgia Veterans Health System, Gainesville, Florida4
Received 5 March 2007/ Returned for modification 25 April 2007/ Accepted 12 May 2007
We developed a high-performance liquid chromatography (HPLC) assay to validate time-kill and postantifungal-effect (PAFE) experiments for voriconazole against Candida albicans, Candida glabrata, and Candida parapsilosis isolates. Voriconazole exerted prolonged fungistatic activity but no PAFE at concentrations achievable in human sera. HPLC confirmed that experiments were conducted at the desired steady-state voriconazole concentrations.
Published ahead of print on 21 May 2007.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»